COURTNEY ROTH: Open Payments
NPI 1033622725 · POWELL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,692 in 79 payments from 33 companies in 2025. Trend: 2023 $1,782 · 2024 $2,269 · 2025 $2,692
Food & beverage: $1,477Long term medical supply or device loan: $1,115Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $1,292 |
| Janssen Biotech, Inc. | 5 | $251 |
| Incyte Corporation | 4 | $93 |
| Astellas Pharma US Inc | 4 | $83 |
| Genentech USA, Inc. | 4 | $79 |
| Daiichi Sankyo Inc. | 3 | $74 |
| Celgene Corporation | 3 | $66 |
| ABBVIE INC. | 3 | $65 |
| TAIHO ONCOLOGY, INC. | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
Products named: KISQALI, ERLEADA, RYBREVANT, REBLOZYL, JAKAFI, LONSURF, VERZENIO, Enhertu.
Industry payments across TN — which companies pay providers there.
